Kenvue
Markets OTC medicines and personal-care brands including Tylenol, Neutrogena, and Listerine worldwide.
$19.17
After-hours close+0.00 (+0.03%)
At close$19.17(−0.18%)
Something off on this page? Send us feedback.
Breakdown13F · Form 4
Institutions 97.83%1.88B sharesInsiders 1.47%28.15M sharesOther 0.70%13.48M shares
Shares outstanding 1.92B · Float 1.92B · 99.9% free float
Institutions13F, as of Jun 30, 2026
1,031 holders · 1.88B shares · 109 new positions · 519 increased · 366 reduced · 119 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| FMR LLC | 157.05M | 8.18% | +21.96M | Aug 13, 2026 |
| BlackRock, Inc. | 150.83M | 7.86% | +5.53M | Aug 7, 2026 |
| Vanguard Capital Management LLC | 125.31M | 6.53% | +890.5K | Aug 13, 2026 |
| State Street Corp | 121.62M | 6.33% | +2.05M | Aug 7, 2026 |
| Vanguard Portfolio Management LLC | 93.30M | 4.86% | +839.4K | Aug 13, 2026 |
| Geode Capital Management, LLC | 52.02M | 2.71% | +751.1K | Aug 12, 2026 |
| Pentwater Capital Management LP | 51.13M | 2.66% | −870.0K | Aug 14, 2026 |
| Independent Franchise Partners LLP | 50.43M | 2.63% | +1.22M | Aug 13, 2026 |
Beneficial owners13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| Vanguard Capital Management | 7.50% | 143.92M | 13G | Apr 30, 2026 ↗ |
| FMR LLC | 7.00% | 135.09M | 13G | May 6, 2026 ↗ |
InsidersForm 4
| Insider | Role | Shares | % outstanding | Filed |
|---|---|---|---|---|
| Jeffrey C. Smith | director | 27.31M | 1.42% | Dec 15, 2025 |
| Thibaut Mongon | director, officer: Chief Executive Officer | 216.5K | 0.01% | Mar 7, 2025 |
| Carlton Lawson | officer: Group President EMEA & LA | 111.4K | 0.01% | Mar 12, 2026 |
| Meredith Stevens | officer: Chief Operations Officer | 93.1K | 0.00% | Mar 12, 2026 |
| Kirk Perry | officer: Chief Executive Officer | 62.6K | 0.00% | Dec 23, 2025 |
| Luani Alvarado | officer: Chief People Officer | 61.1K | 0.00% | Mar 12, 2026 |
| Paul Ruh | officer: Chief Financial Officer | 56.2K | 0.00% | Mar 7, 2025 |
| Caroline Tillett | officer: Chief Scientific Officer | 56.2K | 0.00% | Dec 17, 2025 |
| Bing Xie | officer: Group President APAC | 47.6K | 0.00% | Mar 7, 2025 |
| Jan Meurer | officer: Group President, North America | 33.2K | 0.00% | Mar 7, 2025 |
1 ten-percent owner holds 182.33M shares by Form 4, outside the officers-and-directors figure above · 5 people have not refiled in the last 18 months (38.9K shares), so they are not in the figure above
Latest trades
| Date | Insider | Type | Shares | Avg price | Owned after |
|---|---|---|---|---|---|
| Jun 10, 2026 | Heather Howlettofficer: CFO & CAO | Sale | 3,700 | $18.11 | 29,288 |
| May 8, 2026 | Matthew Orlandoofficer: General Counsel | Sale | 38,491 | $17.66 | 0 |
| Dec 11, 2025 | Jeffrey C. Smithdirector | Purchase | 3,177,694 | $17.43 | 24,107,632 |
| Dec 12, 2025 | Jeffrey C. Smithdirector | Purchase | 3,200,000 | $17.37 | 27,307,632 |
CongressHouse and Senate disclosures
| Member | Type | Amount | Owner | Traded | Disclosed |
|---|---|---|---|---|---|
| Rep. Kevin Hern · OK01 | Sale | $1,001 – $15,000 | Joint | Aug 5, 2026 | Aug 11, 2026 ↗ |
| Rep. Gilbert Cisneros · CA31 | Purchase | $1,001 – $15,000 | Jun 16, 2026 | Jul 3, 2026 ↗ |